1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Germany Clinical Chemistry Market Outlook to 2021

Germany Clinical Chemistry Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 53 pages

Germany Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "Germany Clinical Chemistry Market Outlook to 2021", provides key market data on the Germany Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the Germany Clinical Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Germany Clinical Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Clinical Chemistry Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Clinical Chemistry Market, Germany 9
3.1 Clinical Chemistry Market, Germany, Revenue ($m), 2007-2014 9
3.2 Clinical Chemistry Market, Germany, Revenue ($m), 2014-2021 11
3.2.1 Clinical Chemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Therapeutic Drug Monitoring Market, Germany, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Urine Analysis Market, Germany, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Clinical Chemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Therapeutic Drug Monitoring Market, Germany, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Urine Analysis Market, Germany, Revenue ($m), by Segment, 2014-2021 23
3.3 Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), 2013-2014 25
3.4 Clinical Chemistry Market, Germany, Company Share by Revenue ($m), 2014 26
4 Overview of Key Companies in Germany, Clinical Chemistry Market 28
4.1 Siemens Healthcare 28
4.1.1 Company Overview 28
4.2 F. Hoffmann-La Roche Ltd. 28
4.2.1 Company Overview 28
4.3 Abbott Laboratories 28
4.3.1 Company Overview 28
4.4 Ortho-Clinical Diagnostics Inc. 29
4.4.1 Company Overview 29
4.5 Mindray Medical International Limited 29
4.5.1 Company Overview 29
4.6 ELITech Group 29
4.6.1 Company Overview 29
5 Clinical Chemistry Market Pipeline Products 30
6 Financial Deals Landscape 33
6.1 Partnerships 33
6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 33
6.1.2 Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 34
6.2 Venture Financing 35
6.2.1 Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 35
7 Recent Developments 37
7.1 Financial Announcements 37
7.1.1 Apr 28, 2015: Analytik Jena Enjoying Solid Start to New Financial Year 37
7.1.2 Apr 22, 2015: Noxilizer and Getinge-La Calhene announce exclusive global supply agreement for Noxilizer to provide NOX FLEX Rapid Biodecontamination systems for Getinge isolators - providing a new solution for the bio-pharmaceutical industry 37
7.1.3 Mar 30, 2015: 100th Patent in Three Years: The Result of a Successful Patent Strategy 40
7.1.4 Mar 26, 2015: Rockwell Medical Announces Triferic Clinical Data Selected for Four Poster Presentations at National Kidney Foundation Spring Clinical Meetings March 26-29, 2015 in Dallas, Texas 41
7.1.5 Mar 26, 2015: Eckert and Ziegler's Annual Report 2014: Weak Therapy segment puts a strain on consolidated profit 43
7.1.6 Feb 04, 2015: Drug-eluting technologies for PAD treatments take centre stage at LINC 2015 44
7.1.7 Nov 27, 2014: Analytik Jena Devaluation Of The Ruble Necessitates Value Adjustment In The Project Business And Leads To A Clearly Negative Operating Result 46
7.2 Other Significant Developments 46
7.2.1 Feb 17, 2015: SGS Introduces Amino Acid Analytical Services At Its Taunusstein, Germany, Facility 46
7.2.2 Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services 47
7.3 Product News 47
7.3.1 Apr 27, 2015: Analytik Jena Launches New Gene Assembly Robot at SynBioBETA London 2015 47
7.3.2 Jan 21, 2015: Analytik Jena Launches CE IvD Kits for Dementia Diagnostics 48
7.4 Strategy And Business Planning 49
7.4.1 Nov 06, 2014: Analytik Jena Establishes Subsidiary in India 49
8 Appendix 50
8.1 Research Methodology 51
8.1.1 Coverage 51
8.1.2 Secondary Research 51
8.1.3 Primary Research 51
8.1.4 Company Share Analysis 52
8.1.5 Distribution Share Analysis 52
8.2 GlobalData Consulting 52
8.3 Contact Us 52
8.4 Disclaimer 53

1.1 List of Tables
Table 1: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Table 7: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Table 8: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 25
Table 10: Clinical Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 27
Table 11: Clinical Chemistry Market Pipeline Products 30
Table 12: NoemaLife Enters into Distribution Agreement with Horiba Medical 33
Table 13: Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 34
Table 14: Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 35

1.2 List of Figures
Figure 1: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Figure 7: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Figure 8: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Clinical Chemistry Market, Germany, Company Share (%) 2014 26

Companies Mentioned
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Ortho-Clinical Diagnostics Inc.
Mindray Medical International Limited
ELITech Group

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 23500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging ...

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

  • $ 23500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com new ...

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

  • $ 21800
  • Industry report
  • October 2016
  • by Venture Planning Group

The new seven-country market intelligence and technology assessment study from VPGMarketResearch.com was designed to help current suppliers and potential market entrants identify and evaluate emerging ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.